logo-loader
LON:MTFB

Motif Bio PLC

Receive alerts
Market:
LON
Market Cap:
£8.02 m
Price
£0.02
Change
-6.52%
52 weeks high
44.90
52 weeks low
2.00

Viewing results 1-3 of 3

Health

Motif Bio prepares for new iclaprim study

Motif’s lead drug candidate is iclaprim, a next-generation antibiotic for which it was seeking US FDA approval for use in patients with acute bacterial skin and skin structure infections ...

4 weeks, 1 day ago
Tech

Amphion Innovations keen to hold onto Polarean Imaging stake

Amphion Innovations provides “concentrated but well-managed portfolio” in high growth sectors...

on 13/8/19
Tech

Amphion Innovations provides “concentrated but well-managed portfolio” in high growth sectors

The company invests and helps build companies in the medical and technology sectors, with a target exit valuation of over US$100mln...

on 19/3/19